X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (13) 13
humans (12) 12
index medicus (11) 11
chemotherapy (9) 9
female (9) 9
male (9) 9
adult (8) 8
aged (8) 8
middle aged (8) 8
cancer (6) 6
care and treatment (6) 6
aged, 80 and over (5) 5
metastasis (5) 5
studies (5) 5
tumors (5) 5
antineoplastic agents - therapeutic use (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
clinical trials (4) 4
disease control (4) 4
disease-free survival (4) 4
docetaxel (4) 4
kaplan-meier estimate (4) 4
life sciences (4) 4
lung neoplasms - mortality (4) 4
medical prognosis (4) 4
neoplasm staging (4) 4
patients (4) 4
retrospective studies (4) 4
apoptosis (3) 3
cancer therapies (3) 3
carcinoma, non-small-cell lung - mortality (3) 3
colorectal cancer (3) 3
colorectal neoplasms - drug therapy (3) 3
fluorouracil (3) 3
human health and pathology (3) 3
intravenous administration (3) 3
lung cancer (3) 3
lung cancer, non-small cell (3) 3
lung neoplasms - drug therapy (3) 3
lung neoplasms - pathology (3) 3
lung-cancer (3) 3
non-small cell lung carcinoma (3) 3
oxaliplatin (3) 3
phase-iii (3) 3
platinum (3) 3
prognosis (3) 3
solid tumors (3) 3
survival analysis (3) 3
survival rate (3) 3
1st-line treatment (2) 2
abridged index medicus (2) 2
adenocarcinoma - drug therapy (2) 2
adjuvant treatment (2) 2
analysis (2) 2
angiogenesis inhibitors - therapeutic use (2) 2
antibodies, monoclonal - adverse effects (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
aspartate aminotransferase (2) 2
asthenia (2) 2
bevacizumab (2) 2
bevacizumab - therapeutic use (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
chemoradiotherapy (2) 2
cisplatin (2) 2
colon-cancer (2) 2
colorectal neoplasms - pathology (2) 2
combination (2) 2
complications and side effects (2) 2
concurrent chemoradiotherapy (2) 2
consolidation chemotherapy (2) 2
death (2) 2
diarrhea (2) 2
dosage and administration (2) 2
dose-response relationship, drug (2) 2
drug dosages (2) 2
drug therapy (2) 2
epidemiology (2) 2
fluorouracil - administration & dosage (2) 2
guidelines (2) 2
hematology, oncology and palliative medicine (2) 2
immunotherapy (2) 2
intention to treat analysis (2) 2
ipilimumab (2) 2
irinotecan (2) 2
leucovorin - administration & dosage (2) 2
ligands (2) 2
management (2) 2
maximum tolerated dose (2) 2
medical research (2) 2
medicine & public health (2) 2
medicine, general & internal (2) 2
metastases (2) 2
metastatic colorectal cancer (2) 2
multicenter (2) 2
nivolumab (2) 2
open-label (2) 2
organoplatinum compounds - administration & dosage (2) 2
organoplatinum compounds - therapeutic use (2) 2
pd-1 protein (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 5, pp. 510 - 519
Summary Background Listeriosis is a severe foodborne infection and a notifiable disease in France. We did a nationwide prospective study to characterise its... 
Infectious Disease | MORTALITY | MENINGITIS | INFECTIOUS DISEASES | MONOCYTOGENES | RISK-FACTORS | MANAGEMENT | GUIDELINES | SURVEILLANCE | PREGNANCY | Foodborne Diseases - microbiology | Infant, Newborn, Diseases - epidemiology | Prognosis | Prospective Studies | Humans | Listeriosis - diagnosis | Bacteremia - mortality | Male | Infant, Newborn, Diseases - microbiology | Listeriosis - epidemiology | Mandatory Reporting | Listeria monocytogenes - classification | Adult | Female | Pregnancy Complications, Infectious - microbiology | Infant, Newborn | Meningoencephalitis - epidemiology | France - epidemiology | Meningoencephalitis - mortality | Pregnancy Complications, Infectious - epidemiology | Risk Factors | Listeria monocytogenes - isolation & purification | Hospitalization | Infectious Disease Transmission, Vertical | Pregnancy | Meningoencephalitis - microbiology | Bacteremia - epidemiology | Listeriosis - microbiology | Aged | Population Surveillance | Listeriosis | Neonates | Food-borne diseases | Disease | Brain stem | Clinical trials | Infections | Genomes | Gestation | Epidemiology | Risk factors | Windows (intervals) | Listeria | Meningitis | Public health | Food | Dexamethasone | Bacterial infections | Mortality | Fetuses | Regression analysis | Clustering | Patients | Bacteremia | Meningoencephalitis | Studies | Surveillance | Medical prognosis | Health risk assessment | Cancer | Life Sciences
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 20, pp. 1919 - 1929
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2018, Volume 379, Issue 24, pp. 2342 - 2350
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2017, Volume 35, Issue 34, pp. 3823 - 3829
Journal Article
by Garassino, Marina Chiara and Cho, Byoung-Chul and Kim, Dong-Wan and Kim, Joo-Hang and Kim, Sang-We and Kim, Young-Chul and Mazières, Julien and Vansteenkiste, Johan and Lena, Hervé and Corral Jaime, Jesus and Gray, Jhanelle E and Powderly, John and Chouaid, Christos and Bidoli, Paolo and Wheatley-Price, Paul and Park, Keunchil and Soo, Ross A and Huang, Yifan and Wadsworth, Catherine and Dennis, Phillip A and Rizvi, Naiyer A and Paz-Ares Rodriguez, Luis and Novello, Silvia and Hiret, Sandrine and Schmid, Peter and Laack, Eckart and Califano, Raffaele and Maemondo, Makoto and Chaft, Jamie and Vicente Baz, David and Berghmans, Thierry and Surmont, Veerle and Reck, Martin and Han, Ji-Youn and Holgado Martin, Esther and Belda Iniesta, Cristobal and Oe, Yuichiro and Chella, Antonio and Chopra, Akhil and Robinet, Gilles and Soto Parra, Hector and Thomas, Michael and Cheema, Parneet and Katakami, Nobuyuki and Su, Wu-Chou and Wolf, Juergen and Lee, Jong-Seok and Saka, Hideo and Milella, Michele and Ramos Garcia, Inmaculada and Sibille, Anne and Yokoi, Takashi and Kang, Eun Joo and Atagi, Shinji and Spaeth-Schwalbe, Ernst and Nishio, Makoto and Imamura, Fumio and Gabrail, Nashat and Veillon, Remi and Derijcke, Sofie and Maeda, Tadashi and Zylla, Dylan and Kubiak, Kendra and Santoro, Armando and Uy, Ma. Noemi and Lucien Geater, Sarayut and Italiano, Antoine and Kowalski, Dariusz and Barlesi, Fabrice and Chen, Yuh-Min and Spigel, David and Chewaskulyong, Busyamas and Garcia Gomez, Ramon and Alvarez Alvarez, Rosa and Yang, Chih-Hsin and Hsia, Te-Chun and Denis, Fabrice and Sakai, Hiroshi and Vincent, Mark and Goto, Koichi and Bosch-Barrera, Joaquim and Weiss, Glen and Canon, Jean-Luc and Scholz, Christian and Aglietta, Massimo and Kemmotsu, Hirotsugu and Azuma, Koichi and Bradbury, Penelope and Feld, Ronald and Chachoua, Abraham and Jassem, Jacek and Juergens, Rosalyn and Palmero Sanchez, Ramon and Malcolm, Albert and Vrindavanam, Nandagopal and Kubota, Kaoru and Waller, Cornelius and Waterhouse, David and Coudert, Bruno and Mark, Zsuzsanna and ... and ATLANTIC Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 521 - 536
Immune checkpoint inhibitors are a new standard of care for patients with advanced non-small-cell lung cancer (NSCLC) without tyrosine kinase or anaplastic... 
MULTICENTER | METAANALYSIS | NSCLC | ONCOLOGY | RANDOMIZED CONTROLLED-TRIAL | ATEZOLIZUMAB | IMMUNE CHECKPOINT | NIVOLUMAB | MEDI4736 | CLINICAL ACTIVITY | DOCETAXEL | Lung cancer, Non-small cell | Care and treatment
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 12/2017, Volume 35, Issue 34, pp. 3823 - 3823
Purpose The safety and efficacy of pembrolizumab, a humanized monoclonal antibody against programmed death 1 (PD-1), were assessed in patients with programmed... 
TRIAL | RESPONSES | MELANOMA | ONCOLOGY | PD-1 BLOCKADE | SENSITIVITY | NIVOLUMAB | TUMORS | IPILIMUMAB | CHEMOTHERAPY | DEFICIENCY | Lung Neoplasms - drug therapy | Prognosis | Lung Neoplasms - mortality | Humans | Middle Aged |